Iceland· IS-EU/1/02/201/001-002&005
Protopic
A tacrolimus product containing tacrolimusum inn mónohýdrat, registered in Iceland by LEO Pharma A/S*. The same ATC class is registered in 12 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Tacrolimus is registered in 12 of 19 countries.
Countries holding a registration under ATC D11AH01 (tacrolimus), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 8 of them publish a price we can compare per daily dose
Tacrolimus · ATC D11AH01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Tacrolimusum INN mónohýdrat
- Manufacturer
- LEO Pharma A/S*
- Country
- Iceland (IS)
- ATC code
- D11AH01
- ATC class
- Tacrolimus
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tacrolimus in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaADVAGRAFAstellas Pharma Europe B.V., Leiden
- United StatesASTAGRAF XLAstellas Pharma US, Inc.
- SwedenAdoport 0,5 mg Kapsel, hårdEbb Medical AB
- United KingdomAdoport 0.5mg capsulesSandoz Ltd
- NetherlandsAdport 0,5 mg, capsules, hardEuro Registratie Collectief B.V.
- FinlandAdportSandoz A/S
- SpainADOPORT 0,5 mg CAPSULAS DURAS EFGSandoz Farmaceutica S.A.
- SwitzerlandAdvagraf
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Adport, Dailiport
- Belgium · Adoport, Dailiport
- Bulgaria · Програф
- Cyprus · Prograf, Tacrolimus Accord
- Czechia · Dailiport, Gecrol
- Germany · Crilomus, Dailiport
- Denmark · Adport, Dailiport
- Estonia · Dailiport, Lebsanan
- Spain · Adoport, Cellmune
- Finland · Adport, Adport,
- France · Adoport, Conferoport
- United Kingdom (Northern Ireland) · Adoport, Ascezo
- Greece · Atodrit-Dermo, Eczatope Derm
- Croatia · Atezyrix, Dermitopic
- Hungary · Prograf, Tacrolimus Stada
- Ireland · Prograf, Tacrolimus Accord
- Italy · Adoport, Carelimus
- Liechtenstein · Advagraf, Envarsus
- Lithuania · Dailiport, Lebsanan
- Luxembourg · Prograft, Sumilor
- Latvia · Dailiport, Lebsanan
- Malta · Prograf
- Netherlands · Adport, Conferoport
- Norway · Adport, Advagraf
- Poland · Cidimus, Dailiport
- Portugal · Adoport, Dermitopic
- Romania · Prograf, Tacrolimus Sandoz
- Sweden · Adport, Adport,
- Slovenia · Adoport, Dailiport
- Slovakia · Atezyrix, Dailiport
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e59a5302-652b-4425-a756-929ec2e1eb10 GET /v1/drugs/e59a5302-652b-4425-a756-929ec2e1eb10?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Smyrsli",
"source": "lyfjastofnun",
"atc_raw": "D11AH01",
"marketed": true,
"strength": null,
"ma_number": "EU/1/02/201/001-002&005",
"substance": "Tacrolimusum INN mónohýdrat",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "37315"
}See everything about tacrolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.